| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Eyerising International is proud to introduce repeated low-level red-light therapy for slowing the progression of childhood myopia through the Eyerising Myopia Management Device. The device is non-invasive, available for children aged 3-16, and can be used either as monotherapy or in combination with all other myopia control treatments except low-dose atropine. Note: The Eyerising Myopia Management Device is available exclusively through eye care professionals, and the content on this page is for eye care professionals only. |
| Category: | Hardware & devices, Health & biotech |
| URL: | www.eyerisinginternational.com |
| Operational Status: | |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | |
| Address: | 9-11 Claremont St. South Yarra, Suite 2.05, Melbourne, Victoria 3141, AU |
| State: | Victoria |
| Overseas Operations: | |
| X: | |
| Facebook: | |
| Linkedin: | https://linkedin.com/company/eyerising-international |
| Founders: |
No items found
|
| Awards won: | |
